De­vel­oper pushes ahead with first new build­ing at Lin­coln Yards

Chicago Sun-Times - - TOP NEWS - BY DAVID ROEDER, BUSI­NESS & LA­BOR RE­PORTER droeder@sun­ | @Roed­erDavid

Chicago de­vel­oper Ster­ling Bay said Thurs­day it is mov­ing for­ward with the first new con­struc­tion on its Lin­coln Yards site, a 320,000-square-foot build­ing for life sciences com­pa­nies that need the lat­est in lab space.

The eight-story build­ing will be along the Chicago River on the south­ern end of Lin­coln Yards. A Ster­ling Bay spokes­woman said the pro­ject will be at the south­east cor­ner of Do­minick Street and Con­cord Place once those streets are ex­tended as part of the de­vel­op­ment. She said ground­break­ing will oc­cur in early 2021.

Ster­ling Bay was mo­ti­vated to act by in­ter­est in an ex­ist­ing life sciences build­ing it has at 2430 N. Hal­sted St. A ren­o­va­tion of a build­ing that for­merly was part of Lurie Chil­dren’s Hospi­tal of Chicago, the 120,000-square-foot fa­cil­ity is now 50% leased, the de­vel­oper said.

Its lat­est lease is with the molec­u­lar engi­neer­ing tech­nol­ogy firm Evozyne. The com­pany leased 30,000 square feet and will join the firms Ex­i­cure and Van­qua Bio in the build­ing. The deal is “yet an­other sign that Chicago is an emerg­ing leader in life sciences,” said Andy Gloor, CEO of Ster­ling Bay.

“The ex­pan­sion of our op­er­a­tional ca­pac­ity to 2430 N. Hal­sted is driven by com­mer­cial de­mand for our data-driven molec­u­lar engi­neer­ing tech­nol­ogy,” said Aris The­ol­o­gis, chief busi­ness of­fi­cer of Evozyne. “We have as­sem­bled top life sci­ence ta­lent from across the coun­try and look for­ward to ex­pand­ing our foot­print in Chicago — both in Lin­coln Park and at Lin­coln Yards — in the years to come.”


A ren­der­ing of the pro­posed life sciences build­ing in Lin­coln Yards.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.